Patient Testimonial - Kathy | Chronic Pain

Creative - 10-23-2020 (2).png

“I was experiencing hip pain for almost a year. My quality of life was greatly compromised. No amount of chiropractic was working. Massage therapy would last an hour and then I would be right back where I started. I was taking narcotics which upset my stomach and caused constipation. Anti-inflammatories were of no benefit. The pain during the day would prevent me from taking walks and riding my bike. I would toss and turn all night, never getting a restful sleep. I started cannabinoid therapy and within one month I was feeling substantially better! I am returning to all the activities I love. I am so grateful for this relief. I just regret I didn’t see Dr. Pearson sooner.” -- Kathy 

Chronic pain is one of the most common diagnoses I see in my practice. It can make life unbearable and impact people’s ability to carry out every day activities. It can also impact sleep and lead to depression over time. 

This is a real challenge for physicians, as there aren’t a lot of quality, evidence-based pain management options at our disposal. Cannabinoid-based medicine offers an evidence-based, multimodal treatment option with a lower risk of harm than most other pain management options.


September marks World Alzheimer's Month

September marks World Alzheimer’s Month and this year, the Alzheimer’s community is facing more significant challenges than ever. 

Nearly 750,000 Canadians are living with Alzheimer’s or another dementia. Due to the significant and prolonged changes brought about by the Coronavirus pandemic, many patients are experiencing increases in symptoms including increased agitation, depression, insomnia and aggressive, and sometimes violent, behaviours.

Current pharmaceutical therapies, including antipsychotic medications, may provide some reduction in behavioural symptoms but carry an increased risk of severe side-effects including stroke and death. As a result, many families are proactively asking for safer alternatives.

There is a growing body of evidence for the use of cannabinoid-based medicines in the treatment of dementia-related symptoms and clinically, we’ve been seeing some outstanding outcomes since beginning therapy. I hope you’ll have a quick watch of this video to learn more.